V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20022993 | 20108261 | 1.59 | 66 | Adjuvant (A) | 2018-02-09 | 2018-02-16 | FEC + DOCETAXEL | N | N | 20081106 | FEC + DOCETAXEL |
| 20022994 | 20108261 | 1.63 | 89 | Adjuvant (A) | 2015-01-30 | 2015-01-30 | FEC 100 + DOCETAXEL | N | N | 20081106 | FEC + DOCETAXEL |
| 20022995 | 20108261 | 1.58 | 57.7 | Adjuvant (A) | 2016-02-13 | 2016-03-07 | FEC + DOCETAXEL | N | N | 20081106 | FEC + DOCETAXEL |
| 20022996 | 20108261 | 1.69 | 10 | Adjuvant (A) | null | 2017-10-16 | FEC + DOCETAXEL | N | N | 20081106 | FEC + DOCETAXEL |
| 20022997 | 20009755 | 1.53 | 55.5 | Neo-adjuvant (N) | 2017-01-22 | 2017-02-15 | FEC 100 + DOCETAXEL | N | N | 20081130 | FEC + DOCETAXEL |
| 20022998 | 20009755 | 1.6 | 73 | Adjuvant (A) | 2016-09-04 | 2016-09-04 | FEC + DOCETAXEL | 02 | N | 20081130 | FEC + DOCETAXEL |
| 20022999 | 20009755 | null | 80.9 | null | 2015-07-09 | 2015-07-09 | FEC 100 + DOCETAXEL | N | N | 20081130 | FEC + DOCETAXEL |
| 20023000 | 20009756 | 1.73 | 76.6 | Curative (C) | 2017-01-15 | 2017-02-12 | FEC + DOCETAXEL | 02 | Y | 20081141 | FEC + DOCETAXEL |
| 20023004 | 20009758 | 1.5 | 66.5 | Adjuvant (A) | 2014-07-12 | 2014-08-23 | FEC 100 + DOCETAXEL | N | N | 20081150 | FEC + DOCETAXEL |
| 20023005 | 20009758 | 1.59 | 77.5 | Adjuvant (A) | null | 2015-06-27 | FEC + DOCETAXEL | N | N | 20081150 | FEC + DOCETAXEL |
| 20023006 | 20009758 | null | 62.6 | null | 2014-11-29 | 2014-12-18 | FEC 100 + DOCETAXEL | N | N | 20081150 | FEC + DOCETAXEL |
| 20023007 | 20009759 | 1.7 | 98.8 | Adjuvant (A) | 2017-06-27 | 2017-07-04 | FEC + DOCETAXEL | 02 | null | 20081175 | FEC + DOCETAXEL |
| 20023008 | 20009760 | 1.69 | 53.5 | Neo-adjuvant (N) | 2014-09-12 | 2014-09-19 | FEC + DOCETAXEL | 02 | N | 20081179 | FEC + DOCETAXEL |
| 20023009 | 20009761 | 1.48 | 84 | Neo-adjuvant (N) | 2014-11-04 | 2014-11-15 | FEC 100 + DOCETAXEL | 2 | N | 20081191 | FEC + DOCETAXEL |
| 20023010 | 20070590 | 1.66 | 99.5 | Neo-adjuvant (N) | 2013-12-30 | 2013-12-30 | FEC + DOCETAXEL | 02 | N | 20081193 | FEC + DOCETAXEL |
| 20023011 | 20070590 | 1.55 | 57 | Neo-adjuvant (N) | 2017-07-12 | 2017-07-12 | FEC + DOCETAXEL | 02 | null | 20081193 | FEC + DOCETAXEL |
| 20023012 | 20070590 | null | null | Adjuvant (A) | 2013-06-08 | 2013-06-16 | FEC 100 + DOCETAXEL | N | N | 20081193 | FEC + DOCETAXEL |
| 20023013 | 20137748 | 1.57 | 53.8 | Adjuvant (A) | 2016-06-14 | 2016-07-05 | FEC + DOCETAXEL | 02 | N | 20081204 | FEC + DOCETAXEL |
| 20023014 | 20137748 | 1.7 | 51.9 | Disease modification (D) | 2015-11-08 | 2015-11-29 | FEC 100 + DOCETAXEL | N | null | 20081204 | FEC + DOCETAXEL |
| 20023015 | 20137748 | 1.62 | 70 | Adjuvant (A) | null | 2013-05-15 | FEC + DOCETAXEL | 99 | N | 20081204 | FEC + DOCETAXEL |
| 20023016 | 20009762 | null | 53.7 | null | 2014-03-24 | 2014-04-12 | FEC + DOCETAXEL | N | N | 20081215 | FEC + DOCETAXEL |
| 20023017 | 20009763 | null | null | Neo-adjuvant (N) | 2013-12-26 | 2014-01-02 | FEC + DOCETAXEL | N | N | 20081216 | FEC + DOCETAXEL |
| 20023018 | 20009763 | 1.59 | 78.9 | Curative (C) | 2016-06-15 | 2016-06-17 | FEC 100 + DOCETAXEL | 02 | N | 20081216 | FEC + DOCETAXEL |
| 20023019 | 20009763 | 1.67 | 73.1 | Adjuvant (A) | 2014-06-08 | 2014-06-22 | FEC + DOCETAXEL | 2 | N | 20081216 | FEC + DOCETAXEL |
| 20023020 | 20009763 | null | 132 | Neo-adjuvant (N) | 2013-11-23 | 2013-12-15 | FEC + DOCETAXEL | N | null | 20081216 | FEC + DOCETAXEL |
| 20023021 | 20009763 | 1.61 | 63 | Not known (9) | 2015-08-19 | 2015-09-02 | FEC 100 + DOCETAXEL | N | N | 20081216 | FEC + DOCETAXEL |
| 20023022 | 20143063 | null | null | Adjuvant (A) | null | 2018-02-25 | FEC + DOCETAXEL | null | null | 20081234 | FEC + DOCETAXEL |
| 20023023 | 20143063 | null | 58.6 | Curative (C) | 2013-11-11 | 2013-11-11 | FEC + DOCETAXEL | 02 | N | 20081234 | FEC + DOCETAXEL |
| 20023024 | 20143063 | 1.74 | 89 | Neo-adjuvant (N) | null | 2013-09-14 | FEC + DOCETAXEL | N | N | 20081234 | FEC + DOCETAXEL |
| 20023025 | 20143063 | 1.55 | 65 | Neo-adjuvant (N) | 2017-09-14 | 2017-09-14 | null | 2 | N | 20081234 | FEC + DOCETAXEL |
| 20023026 | 20143063 | 1.73 | 69.7 | Adjuvant (A) | 2013-08-31 | 2013-09-11 | FEC + DOCETAXEL | N | N | 20081234 | FEC + DOCETAXEL |
| 20023027 | 20148724 | 1.6 | 84 | Adjuvant (A) | 2017-04-03 | 2017-04-21 | FEC + DOCETAXEL | 2 | N | 20081255 | FEC + DOCETAXEL |
| 20023028 | 20009764 | 1.7 | 59 | Curative (C) | 2015-05-20 | 2015-06-02 | FEC + DOCETAXEL | 02 | N | 20081257 | FEC + DOCETAXEL |
| 20023029 | 20009765 | 1.63 | 112.8 | Neo-adjuvant (N) | 2013-08-25 | 2013-08-27 | FEC + DOCETAXEL | 2 | N | 20081264 | FEC + DOCETAXEL |
| 20023030 | 20009765 | 1.6 | 76.8 | Neo-adjuvant (N) | 2014-11-06 | 2014-11-13 | FEC + DOCETAXEL | 2 | N | 20081264 | FEC + DOCETAXEL |
| 20023031 | 20009766 | 1.75 | 77.3 | Adjuvant (A) | 2014-04-14 | 2014-04-17 | FEC 100 + DOCETAXEL | 2 | N | 20081270 | FEC + DOCETAXEL |
| 20023032 | 20009766 | 1.69 | 79 | Adjuvant (A) | 2014-07-12 | 2014-08-12 | FEC + DOCETAXEL | N | N | 20081270 | FEC + DOCETAXEL |
| 20023033 | 20009766 | null | 102 | null | 2015-11-08 | 2015-11-24 | FEC + DOCETAXEL | N | N | 20081270 | FEC + DOCETAXEL |
| 20023034 | 20009767 | null | null | Adjuvant (A) | null | 2015-02-24 | FEC 100 + DOCETAXEL | null | null | 20081285 | FEC + DOCETAXEL |
| 20023035 | 20009767 | 1.68 | 79.2 | Adjuvant (A) | 2016-12-20 | 2016-12-29 | FEC 100 + DOCETAXEL | 02 | null | 20081285 | FEC + DOCETAXEL |
| 20023036 | 20009768 | 1.6 | null | Neo-adjuvant (N) | 2017-07-26 | 2017-09-13 | FEC 100 + DOCETAXEL | N | N | 20081301 | FEC + DOCETAXEL |
| 20023037 | 20009768 | 1.65 | 66 | Not known (9) | null | 2016-03-09 | FEC 100 + DOCETAXEL | N | N | 20081301 | FEC + DOCETAXEL |
| 20023038 | 20009769 | 1.54 | 62.4 | Adjuvant (A) | 2015-09-25 | 2015-09-30 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20081309 | FEC + DOCETAXEL |
| 20023039 | 20009769 | null | 67 | Adjuvant (A) | 2014-04-05 | 2014-04-21 | FEC + DOCETAXEL | 2 | N | 20081309 | FEC + DOCETAXEL |
| 20023040 | 20009770 | null | 139 | Adjuvant (A) | null | 2016-02-25 | FEC + DOCETAXEL | null | null | 20081319 | FEC + DOCETAXEL |
| 20023041 | 20009771 | 1.64 | 56.5 | Curative (C) | null | 2014-04-01 | FEC 100 + DOCETAXEL | N | N | 20081323 | FEC + DOCETAXEL |
| 20023042 | 20009771 | 1.68 | 65 | Not known (9) | 2018-02-04 | 2018-02-11 | FEC + DOCETAXEL | 02 | N | 20081323 | FEC + DOCETAXEL |
| 20023043 | 20009772 | 1.59 | 56 | Adjuvant (A) | 2014-08-09 | 2014-08-21 | FEC + DOCETAXEL | N | N | 20081332 | FEC + DOCETAXEL |
| 20023044 | 20009773 | 1.56 | 75 | Adjuvant (A) | 2017-06-23 | 2017-07-03 | FEC + DOCETAXEL | 2 | N | 20081334 | FEC + DOCETAXEL |
| 20023045 | 20009773 | null | null | Neo-adjuvant (N) | 2016-02-24 | 2016-03-21 | FEC + DOCETAXEL | N | N | 20081334 | FEC + DOCETAXEL |